Midazolam: A review of therapeutic uses and toxicity

Journal of Emergency Medicine

Volumn 15, Issue 3, 1997, Pages 357-365

  Nordt, Sean Patrick ^a   Clark, Richard F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Conscious sedation; Flumazenil; Midazolam; Status epilepticus; Toxicity

Indexed keywords

4 AMINOBUTYRIC ACID; AMOBARBITAL; BENZODIAZEPINE RECEPTOR; CHLORAL HYDRATE; CHLORIDE CHANNEL; CHLORIDE ION; CHLORPROMAZINE; CIMETIDINE; CYTOCHROME P450; DIAZEPAM; FENTANYL; FLUMAZENIL; HALOPERIDOL; MACROLIDE; MIDAZOLAM; OMEPRAZOLE; ORAL CONTRACEPTIVE AGENT; PETHIDINE; PROMETHAZINE; RANITIDINE; RIFAMPICIN; SUFENTANIL;

AMNESIA; ANESTHESIA INDUCTION; ASTHMATIC STATE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG RECEPTOR BINDING; ENDOTRACHEAL INTUBATION; GRAND MAL SEIZURE; HEART ARREST; HEART VENTRICLE TACHYCARDIA; HICCUP; HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RESPIRATION DEPRESSION; REVIEW; SEDATION;

CONSCIOUS SEDATION; DRUG INTERACTIONS; EMERGENCY SERVICE, HOSPITAL; HUMANS; HYPNOTICS AND SEDATIVES; METABOLIC CLEARANCE RATE; MIDAZOLAM; TISSUE DISTRIBUTION;

EID: 0030806927     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(97)00022-X     Document Type: Review

References (83)

1. Kupietzky A, Houpt MI. Midazolam: a review of its use for conscious sedation in children. Pediatr Dent. 1993;15:237-41.
2. Greenblatt DJ, Abemethy DR. Midazolam pharmacology and pharmacokinetics. Anesth Rev. 1985;12:17-20.
3. Glass PS, Jhaveri RM, Ginsberg B, Ossey K. Evaluation of flumazenil for reversing the effects of midazolam-induced conscious sedation or general anesthesia. South Med J. 1993;86:1238-47.
4. Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam: a review of its pharmacological properties and therapeutic use. Drugs. 1984;28:519-43.
5. Kanto J, Allonen H. Pharmacokinetics and the sedative effect of midazolam. Int J Clin Pharmacol Ther Toxicol. 1983;21:460-3.
6. Reves JG, Fragen RJ, Vinik R, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology. 1985;62:310-24.
7. Cole SG, Brozinsky S, Isenberg JI. Midazolam, a new more potent benzodiazepine, compared with diazepam: a randomized, double-blind study of preendoscopic sedatives. Gastrointest Endosc. 1983; 3:219-22.
8. Milgrom P, Beirne OR, Eiset L, Weinstein P, Tay KM, Martin M. The safety and efficacy of outpatient midazolam for oral surgery with and without fentanyl. Anesth Prog. 1993;40:57-62.
9. Wright SW, Chudnofsky CR, Dronen SC, et al. Comparison of midazolam and diazepam for conscious sedation in the emergency department. Ann Emerg Med. 1993;22:201-5.
10. Van der Bijl P, Roelofse JA. Propofol and midazolam for conscious sedation in a mentally retarded dental patient. Anesth Prog. 1992;38:36-7.
11. Kanto JH. Midazolam: the first water-soluble benzodiazepine, pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy. 1985;5:138-55.
12. Baraff LJ. Conscious sedation of children. Ann Emerg Med. 1994; 24:1170-2.
13. Hartgraves PM, Primosch RE. An effect of oral and nasal midazolam for pediatric dental sedation. J Dent Child. 1994;61:175-81.
14. Taylor JW, Simon KB. Possible intramuscular midazolam-associated cardiorespiratory arrest and death. DICP. 1990;24:695-7.
15. Vree TB, Reekers-Ketting JJ, Fragen RJ, Arts THM. Placental transfer of midazolam and its metabolite 1-hydroxymethylmidazolam in the pregnant ewe. Anesth Anal. 1984;63:31-4.
16. Briggs GG, Freeman RK, Yaffe JJ, eds. Drugs in pregnancy and lactation, 4th ed. Baltimore: Williams & Wilkins; 1994.
17. Kanto J, Sjovall S, Erkkola R, Himberg JJ, Kangas L. Placental transfer and maternal midazolam kinetics. Clin Pharmacol Ther. 1983;33:786-91.
18. Baurer TM, Ritz R, Haberthur C, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet. 1995;346:145-7.
19. Klotz U, Arvela P, Rosenkranz B. Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam. Clin Pharmacol Ther. 1985;38:652-5.
20. Fee JPH, Collier PS, Howard PJ, Dundee JW. Cimetidine and ranitidine increase midazolam bioavailability. Clin Pharmacol Ther. 1987;41:80-4.
21. Stanski DR, Hudson RJ. Midazolam pharmacology and pharmacokinetics. Anesth Rev. 1985;12:21-3.
22. Vree TB, Shimoda M, Driessen JJ. Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients. Clin Pharmacol Ther. 1989;46:537-44.
23. Greenblatt DJ, Shader RI, Abernathy DR. Current status of benzodiazepines. N Engl J Med. 1983;309:354-8.
24. Study RE, Barker JL. Cellular mechanisms of benzodiazepine action. JAMA. 1982;247:2147-51.
25. Amrein R, Hetzel W. Pharmacology of drugs frequently used in ICUs: midazolam and flumazenil. Int Care Med. 1991;17:S1-S10.
26. Silvasi DL, Rosen DA, Rosen KR. Continous intravenous midazolam infusion for sedation in the pediatric intensive care unit. Anesth Analg. 1988;67:286-8.
27. Rivera R, Segnini M, Baltodano A, Perez V. Midazolam in the treatment of status epilepticus in children. Crit Care Med. 1993; 21:991-4.
28. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology. 1994;44:1837-40.
29. Orebaugh SL, Bradford SM. Intravenous versus intramuscular midazolam in treatment of chemically induced generalized seizures in swine. Am J Emerg Med. 1994;12:284-7.
30. Wroblewski BA, Joseph AB. The use of intramuscular midazolam for acute seizure cessation or behavioral emergencies in patients with traumatic brain injury. Clin Neuropharmacol. 1992;15:44-9.
31. Ramoska EA, Linkenheimer R, Glasgow C. Midazolam use in the emergency department. J Emerg Med. 1991;9:247-51.
32. Kenny JF, Molloy K, Pollock M, Ortiz MT. Rapid-sequence induction technique for orotracheal intubation of adult nontrauma patients in a community hospital setting. Ann Emerg Med. 1995; 25:432-3.
33. Raeburn D, Miller LG, Summer WR. Peripheral type benzodiazepine receptor and airway smooth muscle relaxation. J Pharmacol Exp Ther. 1988;245:557-62.
34. Koga Y, Sato S, Sodeyama N, et al. Comparison of the relaxant effects of diazepam, flunitrazepam and midazolam on airway smooth muscle. Br J Anaesth. 1992;69:65-9.
35. Saarnivaara L, Lindgren L, Klemola UM. Comparison of chloral hydrate and midazolam by mouth as premedicants in children undergoing otolaryngological surgery. Br J Anaesth. 1988;61:390-6.
36. DeJong PC, Verburg MP. Comparison of rectal to intramuscular administration of midazolam and atropine for premedication of children. Acta Anaesth Scand. 1988;32:485-9.
37. Coughlin MW, Panuska HJ. Direct comparison of midazolam and diazepam for conscious sedation in outpatient oral surgery. Anesth Prog. 1989;36:150-68.
38. Green CJ. Options for sedating children. West J Med. 1993;159: 596-7.
39. Terndrup TE, Dire DJ, Madden CM, Gavula D, Cantor RM. Comparison of intramuscular meperidine and promethazine with and without chlorpromazine: a randomized, prospective, double-blind trial. Ann Emerg Med. 1993;22:206-11.
40. Bates BA, Schutzman SA, Fleisher GR. A comparison of intranasal sufentanil and midazolam to intramuscular meperidine, promethazine, and chlorpromazine for conscious sedation in children. Ann Emerg Med. 1994;24:646-51.
41. Knight ME, Roberts RJ. Phenothiazine and butyrophenone intoxication in children. Pediatr Clin North Am. 1986;33:299-309.
42. Wyant M, Diamond BI, O'Neal E, Sloan A, Borison RL. The use of midazolam in acutely agitated psychiatric patients. Psychopharmacol Bull. 1990;26:126-9.
43. Sievers TD, Yee JD, Foley ME, Blanding PJ, Berde CB. Midazolam for conscious sedation during pediatric oncology procedures: safety and recovery parameters. Pediatrics. 1991;88:1172-9.
44. Rodrigo CR, Rosenquist JB. Aminophylline fails to reverse conscious sedation with midazolam in dentistry. Anesth Prog. 1986; 33:152-4.
45. Chemik DA, Clark MS, Davidson AB, et al. Reversal of central nervous system effects by flumazenil after intravenous conscious sedation with midazolam: report of a multicenter clinical study. Clin Ther. 1992;14:861-77.
46. Berman L, Chernik DA, Cooper SA, et al. Reversal of central benzodiazepine effects by intravenous flumazenil after conscious sedation with midazolam and opioids: a multicenter clinical study. Clin Ther. 1992;14:878-94.
47. Gross JB, Weller RS, Conard P. Flumazenil antagonism of midazolam-induced ventilatory depression. Anesthesiology. 1991;75: 179-85.
48. Mora CT, Torjman M, White PF. Effects of diazepam and flumazenil on sedation and ventilatory response. Anesth Anal. 1989;68: 473-8.
49. Spivey WH, Roberts JR, Derlet RW. A clinical trial of escalating doses of flumazenil for reversal of suspected benzodiazepine overdose in the emergency department. Ann Emerg Med. 1993;22: 1813-21.
50. Bailey PL, Pace ML, Ashburn MA, Moll JWB, East KA, Stanley TH. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology. 1990;73:826-30.
51. Mordel A, Winkler E, Almog S, Tirosh M, Ezra D. Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose. Crit Care Med. 1992;20: 1733-4.
52. Lheureux P, Vranckx M, Leduc D, Askenasi R. Flumazenil in mixed benzodiazepine/tricyclic antidepressant overdose: a placebo controlled study in the dog. Am J Emerg Med. 1992;10:184-8.
53. Doyle WL. Perrin L. Emergence delirium in a child given oral midazolam for conscious sedation. Ann Emerg Med. 1994:24: 1173-5.
54. Feld LH. Negus JB. White PF. Oral midazolam preanesthetic medication in pediatric outpatients. Anesthiology. 1990;73:831-4.
55. Anonymous, Midazolam - is antagonism justified? Lancet. 1988; 2:388-9.
56. Olin BR. ed. Drug facts and comparisons, 47th ed. St Louis: Facts and Comparisons; 1994.
57. Hennes HM, Wagner V. Bonadio WA, et al. The effect of oral midazolam on anxiety of preschool children during laceration repair. Ann Emerg Med. 1990:1006-9.
58. Connors K, Terndrup TE. Nasal versus oral midazolam for sedation of anxious children undergoing laceration repair. Ann Emerg Med. 1994;24:1074-9.
59. Lugo Ra. Fishbein M, Nahata MC, Lininger B. Complication of intranasal midazolam. Pediatrics. 1993;92:638.
60. Zedie N. Amory DW, Wagner BK, O'Hara DA. Comparison of intranasal midazolam and sufentanil premedication in pediatric out patients. Clin Pharmacol Ther. 1996;59:341-8.
61. Shane SA, Fuchs SM. Rhine H. Efficacy of rectal midazolam for the sedation of preschool children undergoing laceration repair. Ann Emerg Med. 1994;24:1065-73.
62. Robb ND, Hargrave SA. Tolerance to intravenous midazolam as a result of oral benzodiazepine therapy: a potential problem for the provision of conscious sedation in dentistry. Anesth Pain Cont Dent. 1993;2:94-7.
63. Vaster M. Nichols DG. Deshpande JK, Wetzel RC. Midazolamtenianyl intravenous sedation in children: case report of respiratory arrest/Pediatrics. 1990;86:463-7.
64. Classen DC. Pestonik SL. Evans RS, Burke JP. Intensive surveillance of midazolam use in hospitalized patients and the occurrence of cardiopulmonary arrest. Pharmacotherapy. 1992;12:213-6.
65. Roelofse JA, Van der Bijl P, Joubert JJ, Breytenbach HS. Blood oxygen saturation levels during conscious sedation with midazolam. S Afr Med J. 1986;70:801-2.
66. Rodrigo MRC, Rosenquist JB. Effect of conscious sedation with midazolam on oxygen saturation. J Oral Maxillofac Surg. 1988; 46:746-50.
67. Ackerman WE, Phero JC, Theodore GT. Ineffective ventilation during conscious sedation due to chest wall rigidity after intravenous midazolam and fentanyl. Anesth Prog. 1990:46-8.
68. Alexander CM, Teller LE, Gross .IB. Slow injection does not prevent midazolam-induced ventilatory depression. Anesth Anal. 1992;74:260-4.
69. Arcos GJ. Midazolam-induced ventricular irritability. Anesthiology. 1987;67:612.
70. Yakel DL, Whittaker S, Eislad MR. Midazolam-induced angioedema and bronchoconstriction. Crit Care Med. 1992;20:307-8.
71. Fujita Y, Ishikawa H, Yokota K. Anaphylactoid reaction to miduzolam. Anesth Anal. 1994;79:808-18.
72. Lobo BL, Miwa L.I. Midazolam disinhibition reaction. DICP. 1988;22:725.
73. Fiset L. Milgrom P. Beirne OR. Roy-Byrne P. Disinhibition of behaviors with midazolam: report of a case J Oral Maxillofac Surg. 1992;50:645-9.
74. Vorsanger GJ, Roberts JT. Midazolam-induced athetoid movements of the lower extremities during epidural anesthesia reversed by physostigmine. J Clin Anesth. 1993;5:494-6.
75. Bergman I. Sleeves M, Buckart G. Thompson A. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pedtatr. 1991;119:644-9.
76. Van Engelen BGM. Gimbrere JS, Booy LH. Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Ann Pharmacother. 1993;27:579-81.
77. Malamed SF. Nikchevich D, Block J. Anterograde amnesia as a possible postoperative complication of midazolam as an agent for intravenous conscious sedation. Anesth Prog. 1988;35:160-2.
78. Rodriguez-Nunez A. Redondo L. Martinon JM. Hiccups due to midazolam in children. Eur J Pediatr. 1993;152:271.
79. Gugler R, Jensen JC. Omperazole inhibits oxidative drug metabolism, studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro. Gastroenterology. 1985;89:1235-41.
80. Olkkola KT, Aranko K, Luurila H. et al. A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther. 1993;53:298-305.
81. Abernethy DR, Greenblatt D.I. Divoli M, Arendt R. Ochs HR, Shader RI. Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids. N Engl J Med. 1982; 306:791-2.
82. Ohnhaus EE, Brockmeyer N. Dylewicz P, Habicht H. The effect of antipyrine and rifampin on the metabolism of diazepam. Clin Pharmacol Ther. 1987;42:148-56.
83. Bonfiglio MF, Dasta JF. Clinical significance of the benzodiazepine-theophylline interaction. Pharmacotherapy. 1991;11:85-7.